Table of Content

Table of Contents

Global Hepatic Encephalopathy Drug Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 RBX-2660 -Product Introduction and Major Manufacturers
1.1.2 KLS-13019 -Product Introduction and Major Manufacturers
1.1.3 GR-3027 -Product Introduction and Major Manufacturers
1.1.4 SYNB-1020 -Product Introduction and Major Manufacturers
1.1.5 Others -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Hepatic Encephalopathy Drug Status and Prospect (2015-2026)
2.1.1 China Hepatic Encephalopathy Drug Market Size and Growth Rate (2015-2026)
2.1.2 China Hepatic Encephalopathy Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Hepatic Encephalopathy Drug Status and Prospect (2015-2026)
2.2.1 EU Hepatic Encephalopathy Drug Market Size and Growth Rate (2015-2026)
2.2.2 EU Hepatic Encephalopathy Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Hepatic Encephalopathy Drug Status and Prospect (2015-2026)
2.3.1 USA Hepatic Encephalopathy Drug Market Size and Growth Rate (2015-2026)
2.3.2 USA Hepatic Encephalopathy Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Hepatic Encephalopathy Drug Status and Prospect (2015-2026)
2.4.1 Japan Hepatic Encephalopathy Drug Market Size and Growth Rate (2015-2026)
2.4.2 Japan Hepatic Encephalopathy Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Hepatic Encephalopathy Drug Status and Prospect (2015-2026)
2.5.1 India Hepatic Encephalopathy Drug Market Size and Growth Rate (2015-2026)
2.5.2 India Hepatic Encephalopathy Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Hepatic Encephalopathy Drug Status and Prospect (2015-2026)
2.6.1 Southeast Asia Hepatic Encephalopathy Drug Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Hepatic Encephalopathy Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Hepatic Encephalopathy Drug Status and Prospect (2015-2026)
2.7.1 South America Hepatic Encephalopathy Drug Market Size and Growth Rate (2015-2026)
2.7.2 South America Hepatic Encephalopathy Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Hepatic Encephalopathy Drug Status and Prospect (2015-2026)
2.8.1 Hepatic Encephalopathy Drug Market Size and Growth Rate (2015-2026)
2.8.2 Hepatic Encephalopathy Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Hepatic Encephalopathy Drug Market Assessment by Segment
3.1 Global Hepatic Encephalopathy Drug Capacity and Growth Rate
3.2 Global Hepatic Encephalopathy Drug Sales by Type
3.3 Global Hepatic Encephalopathy Drug Sales Revenue by Type
3.4 Global Hepatic Encephalopathy Drug Consumption by Application
4 Global Hepatic Encephalopathy Drug Market Assessment by Regions
4.1 Global Hepatic Encephalopathy Drug Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Hepatic Encephalopathy Drug Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Hepatic Encephalopathy Drug Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Hepatic Encephalopathy Drug Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Hepatic Encephalopathy Drug Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Hepatic Encephalopathy Drug Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Hepatic Encephalopathy Drug Sales Market Share of Manufacturers (2019-2020)
6.3 Global Hepatic Encephalopathy Drug Sales Revenue Market Share of Manufacturers (2019-2020)

7 Hepatic Encephalopathy Drug Competitive Analysis
7.1 Alfa Wassermann S.p.A
7.1.1 Alfa Wassermann S.p.A Company Profiles
7.1.2 Alfa Wassermann S.p.A Product Introduction
7.1.3 Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Cosmo Pharmaceuticals S.p.A
7.2.1 Cosmo Pharmaceuticals S.p.A Company Profiles
7.2.2 Cosmo Pharmaceuticals S.p.A Product Introduction
7.2.3 Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Horizon Pharma Plc
7.3.1 Horizon Pharma Plc Company Profiles
7.3.2 Horizon Pharma Plc Product Introduction
7.3.3 Horizon Pharma Plc Hepatic Encephalopathy Drug Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 KannaLife Sciences, Inc.
7.4.1 KannaLife Sciences, Inc. Company Profiles
7.4.2 KannaLife Sciences, Inc. Product Introduction
7.4.3 KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Ocera Therapeutics, Inc.
7.5.1 Ocera Therapeutics, Inc. Company Profiles
7.5.2 Ocera Therapeutics, Inc. Product Introduction
7.5.3 Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 Rebiotix Inc.
7.6.1 Rebiotix Inc. Company Profiles
7.6.2 Rebiotix Inc. Product Introduction
7.6.3 Rebiotix Inc. Hepatic Encephalopathy Drug Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Spherium Biomed S.L.
7.7.1 Spherium Biomed S.L. Company Profiles
7.7.2 Spherium Biomed S.L. Product Introduction
7.7.3 Spherium Biomed S.L. Hepatic Encephalopathy Drug Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Umecrine Cognition AB
7.8.1 Umecrine Cognition AB Company Profiles
7.8.2 Umecrine Cognition AB Product Introduction
7.8.3 Umecrine Cognition AB Hepatic Encephalopathy Drug Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
8 Conclusion

List of Figure

List of Tables and Figures

Figure Product Introduction
Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
Figure Global Hepatic Encephalopathy Drug Production Market Share of Top 5 Players
Table CAGR of Major Market (2021-2026)
Table CAGR in Terms of Production of Each Type (2015-2026)
Table CAGR in Terms of Production of Each Application (2015-2026)
Table Global Hepatic Encephalopathy Drug Sales (K Unit) by Type (2015-2026)
Figure Global Hepatic Encephalopathy Drug Sales (K Unit) and Growth Rate (2015-2026)
Figure Global Hepatic Encephalopathy Drug Sales Market Share (%) by Type (2019 -2020)
Table Global Hepatic Encephalopathy Drug Sales Value (Million USD) by Type (2015-2026)
Figure Global Hepatic Encephalopathy Drug Sales Value (Million USD) and Growth Rate (2015-2026)
Figure Global Hepatic Encephalopathy Drug Sales Value Market Share (%) by Type (2019-2020)
Table Global Hepatic Encephalopathy Drug Sales (K Unit) by Application (2015-2026)
Figure China Hepatic Encephalopathy Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table China Hepatic Encephalopathy Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure EU Hepatic Encephalopathy Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table EU Hepatic Encephalopathy Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure North America Hepatic Encephalopathy Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table North America Hepatic Encephalopathy Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Japan Hepatic Encephalopathy Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table Japan Hepatic Encephalopathy Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure India Hepatic Encephalopathy Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table India Hepatic Encephalopathy Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Southeast Asia Hepatic Encephalopathy Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table Southeast Asia Hepatic Encephalopathy Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure South America Hepatic Encephalopathy Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table South America Hepatic Encephalopathy Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Middle East and Africa Hepatic Encephalopathy Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table Middle East and Africa Hepatic Encephalopathy Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Table Global Hepatic Encephalopathy Drug Capacity (K Units) and Growth Rate (2015-2026)
Figure Global Hepatic Encephalopathy Drug Capacity (K Units) and Growth Rate (2015-2026)
Table Global Hepatic Encephalopathy Drug Sales (Unit) by Type (2015-2026)
Figure Global Hepatic Encephalopathy Drug Sales(Unit) and Growth Rate (2015-2026)
Table Sales Market Share (%) by Type (2019-2026)
Table Global Hepatic Encephalopathy Drug Sales Revenue (Million USD) by Type (2015-2026)
Figure Global Hepatic Encephalopathy Drug Sales Revenue (Million USD) and Growth Rate (2015-2026)
Table Sales Revenue Market Share (%) by Type (2019-2026)
Table Global Hepatic Encephalopathy Drug Consumption (Unit) by Application (2015-2026)
Figure Global Hepatic Encephalopathy Drug Consumption (Unit) and Growth Rate (2015-2026)
Table Consumption Market Share (%) by Application (2019-2026)
Table Global Hepatic Encephalopathy Drug Production (K Unite) by Regions (2015-2020)
Table Global Hepatic Encephalopathy Drug CAGR (%) in term of Production and Market Share by Regions (2015-2026)
Figure Global Hepatic Encephalopathy Drug Production Share by Regions (2019-2020)
Table Global Hepatic Encephalopathy Drug Sales (K Unite) by Regions (2015-2020)
Table Global Hepatic Encephalopathy Drug CAGR (%) in term of Sales and Market Share by Regions (2015-2026)
Figure Global Hepatic Encephalopathy Drug Sales Share by Regions (2019-2020)
Table Global Hepatic Encephalopathy Drug Sales Revenue (Million USD) by Regions (2015-2020)
Table Global Hepatic Encephalopathy Drug CAGR (%) in term of Sales Revenue and Market Share by Regions (2015-2026)
Figure Global Hepatic Encephalopathy Drug Sales Revenue Share by Regions (2019-2020)
Figure Value Chain Structure of Hepatic Encephalopathy Drug
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of Hepatic Encephalopathy Drug
Figure Cost Structure of Hepatic Encephalopathy Drug in 2020
Table Global Hepatic Encephalopathy Drug Capacity Share of Manufacturers (2019-2020)
Figure Global Hepatic Encephalopathy Drug Capacity Share of Manufacturers (2019-2020)
Table Global Hepatic Encephalopathy Drug Sales Market Share of Manufacturers (2019-2020)
Figure Global Hepatic Encephalopathy Drug Sales Market Share of Manufacturers (2019-2020)
Table Global Hepatic Encephalopathy Drug Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Hepatic Encephalopathy Drug Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Hepatic Encephalopathy Drug Sales Value (Million USD), Growth Rate & Market Share (2021-2026)
Table ????Alfa Wassermann S.p.A Profiles
Table ????Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Product Introduction
Table ????Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Alfa Wassermann S.p.A SWOT Analysis
Table ????Cosmo Pharmaceuticals S.p.A Profiles
Table ????Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Product Introduction
Table ????Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Cosmo Pharmaceuticals S.p.A SWOT Analysis
Table ????Horizon Pharma Plc Profiles
Table ????Horizon Pharma Plc Hepatic Encephalopathy Drug Product Introduction
Table ????Horizon Pharma Plc Hepatic Encephalopathy Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Horizon Pharma Plc SWOT Analysis
Table ????KannaLife Sciences, Inc. Profiles
Table ????KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Product Introduction
Table ????KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????KannaLife Sciences, Inc. SWOT Analysis
Table ????Ocera Therapeutics, Inc. Profiles
Table ????Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Product Introduction
Table ????Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Ocera Therapeutics, Inc. SWOT Analysis
Table ????Rebiotix Inc. Profiles
Table ????Rebiotix Inc. Hepatic Encephalopathy Drug Product Introduction
Table ????Rebiotix Inc. Hepatic Encephalopathy Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Rebiotix Inc. SWOT Analysis
Table ????Spherium Biomed S.L. Profiles
Table ????Spherium Biomed S.L. Hepatic Encephalopathy Drug Product Introduction
Table ????Spherium Biomed S.L. Hepatic Encephalopathy Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Spherium Biomed S.L. SWOT Analysis
Table ????Umecrine Cognition AB Profiles
Table ????Umecrine Cognition AB Hepatic Encephalopathy Drug Product Introduction
Table ????Umecrine Cognition AB Hepatic Encephalopathy Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Umecrine Cognition AB SWOT Analysis